[{"name":"SY 1.3 - Primovist matters in the non-cirrhotic patients \u003Csmall\u003E(ID 1157)\u003C\/small\u003E","mode":"","public":true,"info":{"id":1157,"presentation":"SY 1.3 - Primovist matters in the non-cirrhotic patients \u003Csmall\u003E(ID 1157)\u003C\/small\u003E","session":"SY 1 - BAYER: Primovist 2020: how the choice of MR contrast agent influences the management of patients with liver diseases","presenter":"M. Karcaaltincaba, Ankara, TR","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/86\/v\/1157_2p.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/esgar2020\/86\/v\/1157_2p.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/86\/77DB9D54.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/86\/v\/1157_2p.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/esgar2020\/86\/v\/1157_2p-thumbnails.vtt"}]}]{"status_url":"https:\/\/cslide.ctimeetingtech.com\/play\/8E22WM0kX\/status","status":20,"track_url":"https:\/\/cslide.ctimeetingtech.com\/play\/8E22WM0kX\/track","track":60,"provider":"CTI","provider_live":0,"type":1,"code":"8E22WM0kX"}